We are live on ! Find out more
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP

Delisted

HZNP was delisted on the 5th of October, 2023.

Back to rankings

2 hedge funds and large institutions have $3.95K invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,305% more capital invested

Capital invested by funds: $116 → $3.95K (+$3.83K)

100% more funds holding

Funds holding: 1 → 2 (+1)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

HZNP Hedge Fund Activity: Q2 2024 in Review

2 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q2 2024, worth a combined $3.95K — up 3,305% from $116 a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new HZNP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q2 2024, up from 1 in Q1 2024.
  • Funds reported $3.95K of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q2 2024, up 3,305% quarter-over-quarter.
  • 1 fund opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q2 2024 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2024.